Biomarker Technologies Market to Grow at 9.7% CAGR to 2022 - Led by Genomics

Major players in Biomarker Technologies market were identified through secondary research & their market revenues determined through primary and secondary research.

The biomarker technologies market is expected to reach USD 74.51 billion in 2022 from USD 46.97 billion in 2017, at a CAGR of 9.7% during the forecast period. The growth of this market is mainly driven by increasing healthcare expenditure and the increase in R&D funding.

Get Free Market Updates Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1509114 .

The biomarker technologies market is highly competitive. The major players in this market are Thermo Fisher Scientific (US), Agilent Technologies (US), Roche (Switzerland), Danaher Corporation (US), Waters Corporation (US), Shimadzu Corporation (Japan), and Bio-Rad Laboratories (US). Other important factors aiding the growth of this market include the increasing utility of biomarkers for diagnostic purposes and new initiatives for biomarker research.

Objectives of the Study
• To define, describe, and forecast the biomarker technologies market by test type, product, application, profiling technology, disease indication, system, and research type
• To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and to provide details of the competitive landscape for market leaders
• To forecast the size of the market in North America, Europe, Asia Pacific, and Rest of the World

Percentage splits, shares, & breakdowns of segments were determined using secondary sources and verified through primary sources. Top-down & bottom-up approaches were used to validate size of biomarker technologies market and estimate size of various other dependent submarkets.

Get Discount at http://www.rnrmarketresearch.com/contacts/discount?rname=1509114 .

Immunoassays held the largest share of the biomarker technologies market, by profiling technology, in 2017. Based on profiling technology, the biomarker technologies market is classified into immunoassay, PCR, imaging technology, mass spectrometry, NGS, chromatography, cytogenetics, and other technologies. The immunoassay segment accounted for the largest share of the market.

Key Target Audience
• Hospitals and clinics
• Research institutes and clinical research organizations
• Market research and consulting firms
• Authorities framing reimbursement policies for the use of cancer diagnostics
• Companies offering kits/assays/platforms/technologies for biomarker testing
• Pharmaceutical Companies

Based on disease indication, the biomarker technologies market is classified into cancer, infectious diseases, autoimmune disorders, neurological disorders, cardiovascular disorders, and other disease indications. Cancer accounted for the largest share of the biomarker technologies market, as biomarkers have major applications in cancer research, diagnostics, and treatment.

For More Information on “Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation, Biomarker Discovery) - Global Forecast to 2022” at http://www.rnrmarketresearch.com/contacts/purchase?rname=1509114 .

In this report, the biomarker technologies market is segmented by test type, product, application, profiling technology, disease indication, system, and research type. Specific segments have also been studied based on application—clinical diagnostics, drug discovery & development, and applied research. The biomarker systems market has also been classified based on products used.

Break-up profile of primaries:
• By Company Type: Tier 1–42%, Tier 2–37%, and Tier 3–21%.
• By Designation: C-level–34%, D-level–42%, and Others–24%
• By Region: North America–32%, Europe–30%, Asia–24%, and RoW–14%

Contact:
sales@rnrmarketresearch.com / Call +1 888 391 5441
RnRMarketResearch Provides you the further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.

Mr. Hrishikesh
Tower B5, Office 101,
Magarpatta City SEZ,
Pune-411013, India

This release was published on openPR.